{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shah UA"],"funding":["NCI NIH HHS"],"pagination":["567-574"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7978489"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["126(3)"],"pubmed_abstract":["<h4>Background</h4>Globally, 5 million to 10 million people are infected with human T-cell leukemia virus type 1, which causes adult T-cell leukemia/lymphoma (ATLL) in 2% to 5% of the carriers. ATLL is a rare but extremely aggressive malignancy that can be challenging to diagnose. Very little data exist on the incidence patterns of ATLL in the United States.<h4>Methods</h4>ATLL cases reported to the National Program of Cancer Registries, the Surveillance, Epidemiology, and End Results (SEER) program, and the New York State Cancer Registry were used for the study. Age-adjusted incidence rates were calculated by age, race/ethnicity, sex, and year of diagnosis. The 5-year survival rate was compared among race/ethnicity groups with the SEER data.<h4>Results</h4>During 2001-2015, 2148 ATLL case"],"journal":["Cancer"],"pubmed_title":["Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States."],"pmcid":["PMC7978489"],"funding_grant_id":["P30 CA008748"],"pubmed_authors":["Shah N","Derman O","Qiao B","Janakiram M","Mantzaris I","Pradhan K","Sica RA","Ye BH","Verma A","Shah UA","Braunschweig I","Kornblum N","Shastri A","Acuna-Villaorduna A","Adrianzen Herrera D"],"additional_accession":[]},"is_claimable":false,"name":"Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.","description":"<h4>Background</h4>Globally, 5 million to 10 million people are infected with human T-cell leukemia virus type 1, which causes adult T-cell leukemia/lymphoma (ATLL) in 2% to 5% of the carriers. ATLL is a rare but extremely aggressive malignancy that can be challenging to diagnose. Very little data exist on the incidence patterns of ATLL in the United States.<h4>Methods</h4>ATLL cases reported to the National Program of Cancer Registries, the Surveillance, Epidemiology, and End Results (SEER) program, and the New York State Cancer Registry were used for the study. Age-adjusted incidence rates were calculated by age, race/ethnicity, sex, and year of diagnosis. The 5-year survival rate was compared among race/ethnicity groups with the SEER data.<h4>Results</h4>During 2001-2015, 2148 ATLL case","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Feb","modification":"2025-04-18T16:50:19.655Z","creation":"2025-04-07T04:17:33.975Z"},"accession":"S-EPMC7978489","cross_references":{"pubmed":["31769871"],"doi":["10.1002/cncr.32556"]}}